11/13/2025
Doseology has reached a pivotal milestone, completing extensive North American diligence and securing a strategic U.S. manufacturing agreement through its subsidiary, Doseology USA Inc. This partnership gives the Company the commercial infrastructure, regulatory strength, and scalable production capacity needed to move from R&D into full market readiness. For investors, it signals disciplined ex*****on, lowered operational risk, and a clear path toward commercialization in the fast-growing oral stimulant pouch category.
Read the News Release: https://doseology.com/2025/11/13/doseology-completes-extensive-north-american-diligence-securing-strategic-manufacturing-agreement/
(CSE: MOOD | PINK: DOSEF | FSE: VU70)